Epstein Secrets

rumps-spy-chief-be-trusted/2020/10/22/60e9e33e-14a1-11eb- ad6f-36c93e6e94fb_story.html> (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

ine the Trump administration in its first days." The Daily Caller (1/23, Ross, 375K) reports, "The investigation focused on leaks to Post columnist David Ignatius, who reported on Jan. 12, 2017, that Flynn had spoken with Kislyak, possibly about U.S. sanctions against Russia." The column "set in motion a seri

break from Trump's discursive approach to the pandemic as cases continue to climb nationwide." USA Today (1/24, Rivera, 12.7M) and Politico (1/24, Beasley, 6.73M) also report. US Passes 25M Confirmed Cases; Epidemiologist Pegs Total At More Than 105M. The AP (1/24) says "the new milestone" of 25 milli

m." Ignatius: Ratcliffe Facing "Moment Of Truth." In a column for the Washington Post (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

m." Ignatius: Ratcliffe Facing "Moment Of Truth." In a column for the Washington Pnst (10/22, 14.2M) entitled, "Can Trump's Spy Chief Be Trusted?," David Ignatius writes that DNI Ratcliffe's performance "has often seemed to emphasize...serving the political interests of the man who appointed him, President Tr

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-